Literature DB >> 30152861

The effect of central administration of alpha-pinene on capsaicin-induced dental pulp nociception.

I Rahbar1, M Abbasnejad1, J Haghani2, M Raoof3, R Kooshki1, S Esmaeili-Mahani1.   

Abstract

AIM: To assess the effects of central administration of α-pinene alone and in combination with either bicuculline or naloxone, as GABAA and μ-opioid receptor antagonists, respectively, on capsaicin-induced dental pulp stimulation in rats.
METHODOLOGY: Forty-eight adult male Wistar rats aged 2 months (230-270 g) were cannulated via their lateral ventricles for the central administration of the drugs. α-Pinene was injected at 0.1, 0.2 and 0.4 μmol L-1 . Then, dental pulp stimulation was induced by intradental application of capsaicin solution (100 μg), and nociceptive scores were recorded for up to 40 min. For investigation of the anti-inflammatory effects of α-pinene, expression of COX-2 in the subnucleolus caudalis (Vc) of rats was determined using immunofluorescence staining. Nonparametric repeated measure Friedman and Kruskal-Wallis tests as well as parametric one-way analysis of variance were used for the statistical analysis.
RESULTS: α-Pinene at 0.2 and 0.4 μmol L-1 was able to decrease capsaicin-induced nociception. Moreover, there was a significant increase in the expression of COX-2-positive cells in the Vc of capsaicin-treated rats (P < 0.01). This effect was prohibited by α-pinene (0.4 μmol L-1 ). Co-administration of bicuculline (1 μg per rat) or naloxone (6 μg per rat) with α-pinene (0.4 μmol L-1 ), however, prevented the inhibitory effects of α-pinene on both capsaicin-induced pulp nociception and COX-2 over-expression.
CONCLUSIONS: Pinene exhibited significant curable effects on capsaicin-induced pulpal nociception and inflammation mainly via pharmacological interfacing with GABAA and μ-opioid receptors.
© 2018 International Endodontic Journal. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  alpha-pinene; capsaicin; dental pulp; nociception; pain

Mesh:

Substances:

Year:  2018        PMID: 30152861     DOI: 10.1111/iej.13006

Source DB:  PubMed          Journal:  Int Endod J        ISSN: 0143-2885            Impact factor:   5.264


  6 in total

1.  Developing Forest Therapy Programmes Based on the Health Benefits of Terpenes in Dominant Tree Species in Tara National Park (Serbia).

Authors:  Martina Zorić; Jelena Farkić; Marko Kebert; Emina Mladenović; Dragić Karaklić; Gorana Isailović; Saša Orlović
Journal:  Int J Environ Res Public Health       Date:  2022-05-01       Impact factor: 4.614

Review 2.  Therapeutic Potential of α- and β-Pinene: A Miracle Gift of Nature.

Authors:  Bahare Salehi; Shashi Upadhyay; Ilkay Erdogan Orhan; Arun Kumar Jugran; Sumali L D Jayaweera; Daniel A Dias; Farukh Sharopov; Yasaman Taheri; Natália Martins; Navid Baghalpour; William C Cho; Javad Sharifi-Rad
Journal:  Biomolecules       Date:  2019-11-14

Review 3.  Forest Volatile Organic Compounds and Their Effects on Human Health: A State-of-the-Art Review.

Authors:  Michele Antonelli; Davide Donelli; Grazia Barbieri; Marco Valussi; Valentina Maggini; Fabio Firenzuoli
Journal:  Int J Environ Res Public Health       Date:  2020-09-07       Impact factor: 3.390

4.  The ability of orexin-A to modify pain-induced cyclooxygenase-2 and brain-derived neurotrophic factor expression is associated with its ability to inhibit capsaicin-induced pulpal nociception in rats.

Authors:  Fatemeh Shahsavari; Mehdi Abbasnejad; Saeed Esmaeili-Mahani; Maryam Raoof
Journal:  Korean J Pain       Date:  2022-07-01

5.  α-Pinene Influence on Pulpal Pain-Induced Learning and Memory Impairment in Rats Via Modulation of the GABAA Receptor.

Authors:  Forouzan Rafie; Razieh Kooshki; Mehdi Abbasnejad; Iran Rahbar; Maryam Raoof; Amir Hossein Nekouei
Journal:  Adv Biomed Res       Date:  2022-07-29

Review 6.  Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant.

Authors:  Elaine C D Gonçalves; Gabriela M Baldasso; Maíra A Bicca; Rodrigo S Paes; Raffaele Capasso; Rafael C Dutra
Journal:  Molecules       Date:  2020-03-29       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.